1. Home
  2. ACU vs NKTX Comparison

ACU vs NKTX Comparison

Compare ACU & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$44.80

Market Cap

154.0M

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.33

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
NKTX
Founded
1867
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
132.8M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
ACU
NKTX
Price
$44.80
$2.33
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$13.25
AVG Volume (30 Days)
8.2K
716.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.43%
N/A
EPS Growth
N/A
33.33
EPS
2.03
N/A
Revenue
$194,489,991.00
N/A
Revenue This Year
$2.19
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$22.07
N/A
Revenue Growth
1.56
N/A
52 Week Low
$35.31
$1.31
52 Week High
$45.60
$2.74

Technical Indicators

Market Signals
Indicator
ACU
NKTX
Relative Strength Index (RSI) 57.06 60.28
Support Level $42.98 $1.95
Resistance Level $45.20 $2.42
Average True Range (ATR) 1.17 0.13
MACD -0.07 0.02
Stochastic Oscillator 58.22 80.39

Price Performance

Historical Comparison
ACU
NKTX

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: